Clinical Trial Shows Plant-Derived Cannabis Safe and Effective for Children With Autism

A clinical trial has demonstrated that plant-derived cannabis preparations are both safe and effective in treating children with autism spectrum disorder. After eight weeks of cannabinoid treatment, patients experienced a significant 2-point reduction on a 7-point disease severity scale, indicating meaningful clinical improvement. This research adds to growing evidence supporting cannabis as a potential therapeutic option for managing autism-related symptoms. The findings are particularly significant for families seeking alternative treatment approaches and have important implications for pediatric cannabis therapy development. The trial results suggest cannabinoids may help improve behavioral and symptomatic outcomes in autistic children.